Full Text View
Tabular View
No Study Results Posted
Related Studies
Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
This study is ongoing, but not recruiting participants.
Study NCT00061360   Information provided by National Institutes of Health Clinical Center (CC)
First Received: May 23, 2003   Last Updated: November 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aplastic Anemia
Additional conditions recognized in this trial
Anemia
Anemia, Aplastic
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Interventions listed in this trial
Sirolimus (Rapamune)
Additional drug interventions recognized in this trial
Immunosuppressive Agents
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services